Preloading Diversity into ANZ Clinical Trials 2023
Have you been following the increased demand by regulators and drug development executives for diversity in clinical trials? Have you wondered why this is important? Or why the recruitment of diverse populations for these trials in Australia and New Zealand (ANZ) is often challenging, particularly as an afterthought? Have you ever wondered how you could supplement site based recruitment efforts from the beginning to engineer diversity into your research?
Join us in our groundbreaking webinar, "Preloading Diversity into ANZ Clinical Trials" as we delve into these pivotal issues that are reshaping the clinical research landscape globally.
Our lineup of esteemed speakers, led by Tam Nguyen, Deputy Director of Research at St Vincent's Hospital, Dr Hugo Stephenson, longstanding clinical trials advocate and Head of Opin, Dr Tuong Phan, Specialist Anaesthetist and Clinical Researcher at St Vincent's Hospital Melbourne and University of Melbourne, Professor Lily Xiao, Matthew Flinders Professor College of Nursing & Health Sciences from Flinders University, and Dr. Jakub Hlavka, Associate Professor in Health Policy from USC Keck School of Medicine, will discuss the far-reaching implications of not incorporating diversity into clinical trials from the start.
Engage in an in-depth conversation about:
- The scientific, ethical, and societal consequences of not engineering diversity into clinical trials.
- The changing regulations worldwide that necessitate upfront diversity.
- The unique challenges posed by socioeconomic factors and clinical trial centre locations in Australia and how they impact diverse recruitment.
- The power of community building and network establishment in advance of recruitment.
- The strategies for enhancing site recruitment from day one to incorporate diversity.
From quaternary referral centres to bustling suburbs, we'll tackle how diversity can and should be embraced at every stage of the clinical trial process. Discover how this fundamental shift in approach can transform research outcomes and patient experiences.
This engaging and interactive discussion is designed for academics, researchers, medical professionals, public health advocates, and all those interested in equity in healthcare and scientific research.